Cargando…

Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients

Mutations in the genes of the F(420) signaling pathway of Mycobacterium tuberculosis complex, including dnn, fgd1, fbiA, fbiB, fbiC, and fbiD, can lead to delamanid resistance. We searched for such mutations among 129 M. tuberculosis strains from Asia, South America, and Africa using whole-genome se...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichmuth, Martina L., Hömke, Rico, Zürcher, Kathrin, Sander, Peter, Avihingsanon, Anchalee, Collantes, Jimena, Loiseau, Chloé, Borrell, Sonia, Reinhard, Miriam, Wilkinson, Robert J., Yotebieng, Marcel, Fenner, Lukas, Böttger, Erik C., Gagneux, Sebastien, Egger, Matthias, Keller, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577131/
https://www.ncbi.nlm.nih.gov/pubmed/32868333
http://dx.doi.org/10.1128/AAC.00513-20
_version_ 1783598146938470400
author Reichmuth, Martina L.
Hömke, Rico
Zürcher, Kathrin
Sander, Peter
Avihingsanon, Anchalee
Collantes, Jimena
Loiseau, Chloé
Borrell, Sonia
Reinhard, Miriam
Wilkinson, Robert J.
Yotebieng, Marcel
Fenner, Lukas
Böttger, Erik C.
Gagneux, Sebastien
Egger, Matthias
Keller, Peter M.
author_facet Reichmuth, Martina L.
Hömke, Rico
Zürcher, Kathrin
Sander, Peter
Avihingsanon, Anchalee
Collantes, Jimena
Loiseau, Chloé
Borrell, Sonia
Reinhard, Miriam
Wilkinson, Robert J.
Yotebieng, Marcel
Fenner, Lukas
Böttger, Erik C.
Gagneux, Sebastien
Egger, Matthias
Keller, Peter M.
author_sort Reichmuth, Martina L.
collection PubMed
description Mutations in the genes of the F(420) signaling pathway of Mycobacterium tuberculosis complex, including dnn, fgd1, fbiA, fbiB, fbiC, and fbiD, can lead to delamanid resistance. We searched for such mutations among 129 M. tuberculosis strains from Asia, South America, and Africa using whole-genome sequencing; 70 (54%) strains had at least one mutation in one of the genes. For 10 strains with mutations, we determined the MIC of delamanid. We found one strain from a delamanid-naive patient carrying the natural polymorphism Tyr29del (ddn) that was associated with a critical delamanid MIC.
format Online
Article
Text
id pubmed-7577131
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-75771312020-10-30 Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients Reichmuth, Martina L. Hömke, Rico Zürcher, Kathrin Sander, Peter Avihingsanon, Anchalee Collantes, Jimena Loiseau, Chloé Borrell, Sonia Reinhard, Miriam Wilkinson, Robert J. Yotebieng, Marcel Fenner, Lukas Böttger, Erik C. Gagneux, Sebastien Egger, Matthias Keller, Peter M. Antimicrob Agents Chemother Susceptibility Mutations in the genes of the F(420) signaling pathway of Mycobacterium tuberculosis complex, including dnn, fgd1, fbiA, fbiB, fbiC, and fbiD, can lead to delamanid resistance. We searched for such mutations among 129 M. tuberculosis strains from Asia, South America, and Africa using whole-genome sequencing; 70 (54%) strains had at least one mutation in one of the genes. For 10 strains with mutations, we determined the MIC of delamanid. We found one strain from a delamanid-naive patient carrying the natural polymorphism Tyr29del (ddn) that was associated with a critical delamanid MIC. American Society for Microbiology 2020-10-20 /pmc/articles/PMC7577131/ /pubmed/32868333 http://dx.doi.org/10.1128/AAC.00513-20 Text en Copyright © 2020 Reichmuth et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Susceptibility
Reichmuth, Martina L.
Hömke, Rico
Zürcher, Kathrin
Sander, Peter
Avihingsanon, Anchalee
Collantes, Jimena
Loiseau, Chloé
Borrell, Sonia
Reinhard, Miriam
Wilkinson, Robert J.
Yotebieng, Marcel
Fenner, Lukas
Böttger, Erik C.
Gagneux, Sebastien
Egger, Matthias
Keller, Peter M.
Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients
title Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients
title_full Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients
title_fullStr Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients
title_full_unstemmed Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients
title_short Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients
title_sort natural polymorphisms in mycobacterium tuberculosis conferring resistance to delamanid in drug-naive patients
topic Susceptibility
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577131/
https://www.ncbi.nlm.nih.gov/pubmed/32868333
http://dx.doi.org/10.1128/AAC.00513-20
work_keys_str_mv AT reichmuthmartinal naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT homkerico naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT zurcherkathrin naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT sanderpeter naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT avihingsanonanchalee naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT collantesjimena naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT loiseauchloe naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT borrellsonia naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT reinhardmiriam naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT wilkinsonrobertj naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT yotebiengmarcel naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT fennerlukas naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT bottgererikc naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT gagneuxsebastien naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT eggermatthias naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients
AT kellerpeterm naturalpolymorphismsinmycobacteriumtuberculosisconferringresistancetodelamanidindrugnaivepatients